New Type of CAR T-cells Offers Hope for ‘First Viable’ Treatment of T-cell Blood Cancers, Study Reports
News
A new approach using genetically modified T-cells may become the first clinically viable, targeted immunotherapy for T-cell blood cancers, a preclinical study reports. The study, “An “off-the-shelf” fratricide-resistant CAR-T for ... Read more